Results
|
|
221.
|
Optimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combination. [electronic resource] by
- De Pas, T
- Rosati, G
- Spitaleri, G
- Boni, C
- Tucci, A
- Frustaci, S
- Scalamogna, R
- Radice, D
- Boselli, S
- Toffalorio, F
- Catania, C
- Noberasco, C
- Delmonte, A
- Vecchio, F
- de Braud, F
Producer: 20111027
In:
Chemotherapy vol. 57
Availability: No items available.
|
|
|
222.
|
Mercury in the Black Sea: New Insights From Measurements and Numerical Modeling. [electronic resource] by
- Rosati, G
- Heimbürger, L E
- Melaku Canu, D
- Lagane, C
- Laffont, L
- Rijkenberg, M J A
- Gerringa, L J A
- Solidoro, C
- Gencarelli, C N
- Hedgecock, I M
- De Baar, H J W
- Sonke, J E
Publication details: Global biogeochemical cycles Apr 2018
In:
Global biogeochemical cycles vol. 32
Availability: No items available.
|
|
|
223.
|
A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer. [electronic resource] by
- Ajani, J A
- Abramov, M
- Bondarenko, I
- Shparyk, Y
- Gorbunova, V
- Hontsa, A
- Otchenash, N
- Alsina, M
- Lazarev, S
- Feliu, J
- Elme, A
- Esko, V
- Abdalla, K
- Verma, U
- Benedetti, F
- Aoyama, T
- Mizuguchi, H
- Makris, L
- Rosati, G
Producer: 20180523
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
|
224.
|
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial. [electronic resource] by
- Lonardi, S
- Sobrero, A
- Rosati, G
- Di Bartolomeo, M
- Ronzoni, M
- Aprile, G
- Massida, B
- Scartozzi, M
- Banzi, M
- Zampino, M G
- Pasini, F
- Marchetti, P
- Cantore, M
- Zaniboni, A
- Rimassa, L
- Ciuffreda, L
- Ferrari, D
- Barni, S
- Zagonel, V
- Maiello, E
- Rulli, E
- Labianca, R
Publication details: Annals of oncology : official journal of the European Society for Medical Oncology 12 2017
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
|
225.
|
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial. [electronic resource] by
- Lonardi, S
- Sobrero, A
- Rosati, G
- Di Bartolomeo, M
- Ronzoni, M
- Aprile, G
- Massida, B
- Scartozzi, M
- Banzi, M
- Zampino, M G
- Pasini, F
- Marchetti, P
- Cantore, M
- Zaniboni, A
- Rimassa, L
- Ciuffreda, L
- Ferrari, D
- Barni, S
- Zagonel, V
- Maiello, E
- Rulli, E
- Labianca, R
Producer: 20171226
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|
|
|
226.
|
Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia. [electronic resource] by
- Zoledziewska, M
- Costa, G
- Pitzalis, M
- Cocco, E
- Melis, C
- Moi, L
- Zavattari, P
- Murru, R
- Lampis, R
- Morelli, L
- Poddie, F
- Frongia, P
- Pusceddu, P
- Bajorek, M
- Marras, A
- Satta, A M
- Chessa, A
- Pugliatti, M
- Sotgiu, S
- Whalen, M B
- Rosati, G
- Cucca, F
- Marrosu, M G
Producer: 20090305
In:
Genes and immunity vol. 10
Availability: No items available.
|
|
|
227.
|
A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma. [electronic resource] by
- Rosati, G
- Ambrosini, G
- Barni, S
- Andreoni, B
- Corradini, G
- Luchena, G
- Daniele, B
- Gaion, F
- Oliverio, G
- Duro, M
- Martignoni, G
- Pinna, N
- Sozzi, P
- Pancera, G
- Solina, G
- Pavia, G
- Pignata, S
- Johnson, F
- Labianca, R
- Apolone, G
- Zaniboni, A
- Monteforte, M
- Negri, E
- Torri, V
- Mosconi, P
- Fossati, R
Producer: 20161111
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|
|
|
228.
|
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer. [electronic resource] by
- Bajetta, E
- Floriani, I
- Di Bartolomeo, M
- Labianca, R
- Falcone, A
- Di Costanzo, F
- Comella, G
- Amadori, D
- Pinto, C
- Carlomagno, C
- Nitti, D
- Daniele, B
- Mini, E
- Poli, D
- Santoro, A
- Mosconi, S
- Casaretti, R
- Boni, C
- Pinotti, G
- Bidoli, P
- Landi, L
- Rosati, G
- Ravaioli, A
- Cantore, M
- Di Fabio, F
- Aitini, E
- Marchet, A
Producer: 20150831
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.
|